LILLY-F1J-MC-HMAI

Study Sponsor: Lilly

Study Title

A Double-Blind, Placebo- and Clomipramine-Controlled Study of Duloxetine in Patients with Major
Depression

Medicine or Vaccine (generic name)

Duloxetine hydrochloride

Sponsor Identification Number

F1J-MC-HMAI

Trial Registry Identification Number(#'s)

Not available

Medical Condition

Major Depressive Disorder

Phase

Phase 2

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Not available

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies. Due to the age of this study, the annotated case report form is not available. A blank case report form will be provided.

Date Added to this Site

July 2014